Inhibition of foam cell formation using a soluble CD68-Fc fusion protein
Autor: | Martin Schaller, Karin Müller, Götz Münch, Dagmar Menzel, Thomas Simmet, Tanja Schönberger, Berthold Büchele, Christoph Leder, Dorothea Siegel-Axel, Sandra M Penz, Meinrad Gawaz, Stephan Lindemann, Andreas Bültmann, Karin Daub, Peter Seizer |
---|---|
Rok vydání: | 2010 |
Předmět: |
Platelets
Pathology medicine.medical_specialty Recombinant Fusion Proteins Lipoproteins Phagocytosis Antigens Differentiation Myelomonocytic CHO Cells Biology Matrix metalloproteinase Transfection Mice Apolipoproteins E Cricetulus Antigens CD Cricetinae Drug Discovery Extracellular medicine Animals Humans Macrophage Scavenger receptor Foam cells Genetics (clinical) Foam cell Receptors Scavenger Macrophages Surface Plasmon Resonance Atherosclerosis Fusion protein Molecular biology Plaque Atherosclerotic In vitro Immunoglobulin Fc Fragments Lipoproteins LDL Chemistry Molecular Medicine lipids (amino acids peptides and proteins) Foam Cells |
Zdroj: | Daub, K, Siegel-Axel, D, Schönberger, T, Leder, C, Seizer, P, Müller, K, Schaller, M, Penz, S, Menzel, D, Buchele, B, Bültmann, A, Münch, G, Lindemann, S, Simmet, T & Gawaz, M 2010, ' Inhibition of foam cell formation using a soluble CD68-Fc fusion protein ', Journal of Molecular Medicine, vol. 88, no. 9, pp. 909-920 . https://doi.org/10.1007/s00109-010-0629-y Daub, K, Siegel-Axel, D, Schönberger, T, Leder, C, Seizer, P, Müller, K, Schaller, M, Penz, S, Menzel, D, Büchele, B, Bültmann, A, Münch, G, Lindemann, S, Simmet, T & Gawaz, M 2010, ' Inhibition of foam cell formation using a soluble CD68-Fc fusion protein ' Journal of Molecular Medicine, vol 88, no. 9, pp. 909-920 . DOI: 10.1007/s00109-010-0629-y |
ISSN: | 1432-1440 0946-2716 |
Popis: | The appearance of lipid-rich foam cells is a major feature of vulnerable atherosclerotic plaque formation. The transformation of macrophages into foam cells results from excessive uptake of cholesterol-rich particles by scavenger receptors such as CD68. We cloned a CD68-Fc immunoadhesin, a fusion protein consisting of the extracellular domain of the human CD68 and a human Fc domain, and investigated the function in vitro. Specific binding of CD68-Fc to OxLDL with an affinity of 10 nmol/L was determined by surface plasmon resonance and increased binding to lipid-rich human and ApoE(-/-) mice plaque tissue. This was confirmed both by immunohistochemical staining of CD68-Fc-treated paraffin sections from human plaques and by ELISA-based quantification of CD68-Fc binding to human atherosclerotic plaque extracts. In an in vitro model of macrophage/foam cell formation, CD68-Fc reduced foam cell formation significantly. This was caused both by interference of CD68-Fc with OxLDL uptake into macrophages and platelets and by the inhibition of platelet/OxLDL phagocytosis. Finally, expression of metalloproteinases by macrophages/foam cells was inhibited by CD68-Fc. In conclusion, CD68-Fc seems to be a promising new tool for preventing macrophage/foam cell formation. Thus, CD68-Fc might offer a novel therapeutic strategy for patients with acute coronary syndrome by modulating the generation of vulnerable plaques. The appearance of lipid-rich foam cells is a major feature of vulnerable atherosclerotic plaque formation. The transformation of macrophages into foam cells results from excessive uptake of cholesterol-rich particles by scavenger receptors such as CD68. We cloned a CD68-Fc immunoadhesin, a fusion protein consisting of the extracellular domain of the human CD68 and a human Fc domain, and investigated the function in vitro. Specific binding of CD68-Fc to OxLDL with an affinity of 10 nmol/L was determined by surfaceplasmon resonance and increased binding to lipid-rich human and ApoE−/−mice plaque tissue. This was confirmed both by immunohistochemical staining of CD68-Fc-treated paraffin sections from human plaques and by ELISA-based quantification of CD68-Fc binding to human atherosclerotic plaque extracts. In an in vitro model of macrophage/foam cell formation, CD68-Fc reduced foam cell formation significantly. This was caused both by interference of CD68-Fcwith OxLDL uptake into macrophages and platelets and by the inhibition of platelet/OxLDL phagocytosis. Finally, expression of metalloproteinases by macrophages/foam cells was inhibited by CD68-Fc. In conclusion, CD68-Fc seems to be a promising new tool for preventing macrophage/foamcell formation. Thus, CD68-Fc might offer a novel therapeutic strategy for patients with acute coronary syndrome by modulating the generation of vulnerable plaques. |
Databáze: | OpenAIRE |
Externí odkaz: |